In the end, compounds 86 and 87, which were discovered by exploration of ER degradation and antagonism in vitro followed by in vivo antagonism and culminating in oral exposure, could induce tumor regression in a tamoxifen-resistant breast cancer xenograft. Particularly, compound 187 exerted important body weight reduction in diet plan-induced https://hemalchem.com/product-category/indazole-based/